KATHY JENKINS: Open Payments
NPI 1598917957 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 29 payments from 10 companies in 2025. Trend: 2023 $461 · 2024 $451 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $163 |
| Novo Nordisk Inc | 9 | $160 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| ABBVIE INC. | 1 | $29 |
| MicroTransponder, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Boston Scientific Corporation | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: OTEZLA, Ozempic, Rybelsus, EVENITY, AIRSUPRA, QULIPTA, REPATHA, PAXLOVID.
Industry payments across FL — which companies pay providers there.
